Literature DB >> 7069472

Embolization of cerebral arteriovenous malformations with bucrylate.

G Debrun, F Vinuela, A Fox, C G Drake.   

Abstract

Forty-six patients with cerebral arteriovenous malformations (AVM's) were selected for embolization with bucrylate. These patients were assigned to three different groups. Group I consisted of 22 patients with nonresectable AVM's who were selected for embolization with a Silastic calibrated-leak ballon. In 16 or these patients, embolization was achieved, with partial obliteration of the AVM in 14 and complete obliteration in two. Five patients had subarachnoid hemorrhage caused by the balloon bursting and concomitant dissection of the feeding vessel. Four of these patients recovered completely and one died of a brain-stem hemorrhage. A permanent field defect was noted in five cases, and two patients had a transient mild neurological deficit. Group II consisted of 13 patients treated by intraoperative embolization. Complete obliteration by embolization was obtained in four cases, and complete surgical resection after embolization in five. Partial embolization with no surgical resection was achieved in five cases. Three of these patients had a permanent mild neurological deficit and two had transient deficits. There was no mortality in this group. Group III consisted of 11 patients treated by embolization with bucrylate using a new latex calibrated-leak balloon. This balloon has a higher malleability, and takes on the exact configuration of the feeder, with no risk of dissection. This balloon also permits delivery of the faster and larger injection of bucrylate to the arterial feeders of the AVM. Two AVM's were completely obliterated, and embolization was only partially successful in the other cases. Neurological complications consisted of incomplete field defects in two cases, slight memory loss in one case, and transient clumsiness of the arm and face in one case. Two patients have a catheter permanently glued in the malformation, with no neurological complication. There was no mortality in this group.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7069472     DOI: 10.3171/jns.1982.56.5.0615

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  35 in total

1.  Program requirements for residency/fellowship education in neuroendovascular surgery/interventional neuroradiology: a special report on graduate medical education.

Authors:  R T Higashida; L N Hopkins; A Berenstein; V V Halbach; C Kerber
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

2.  Cerebral arteriovenous malformations.

Authors: 
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

3.  Use of a new mixture for embolization of intracranial vascular malformations. Preliminary experimental experience.

Authors:  P Lylyk; F Viñuela; H V Vinters; J Dion; J Bentson; G Duckwiler; T Lin
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

4.  Revascularization of brain arteriovenous malformations after embolization with bucrylate.

Authors:  D Fournier; K Terbrugge; G Rodesch; P Lasjaunias
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

5.  Dural arteriovenous shunt development in patients with vein of galen malformation.

Authors:  Srinivasan Paramasivam; Yasunari Niimi; Dan Meila; Alejandro Berenstein
Journal:  Interv Neuroradiol       Date:  2014-12-05       Impact factor: 1.610

6.  Predictors of hemorrhagic complications from endovascular treatment of cerebral arteriovenous malformations.

Authors:  José A Jordan; Juan Carlos Llibre; Frank Vázquez; Raúl Rodríguez; José A Prince; José Carlos Ugarte
Journal:  Interv Neuroradiol       Date:  2014-02-10       Impact factor: 1.610

7.  Treatment of cerebral arteriovenous malformation.

Authors:  T Yoshimoto; T Kayama; J Suzuki
Journal:  Neurosurg Rev       Date:  1986       Impact factor: 3.042

8.  The management of cerebral arteriovenous malformations.

Authors:  C Davis; L Symon
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

9.  Early surgical treatment of intracerebral hemorrhages caused by AVM: our experience in 10 cases.

Authors:  F Puzzilli; L Mastronardi; A Ruggeri; P Lunardi
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

10.  Endovascular treatment of cerebral arteriovenous malformations.

Authors:  P Lasjaunias; C Manelfe; K Terbrugge; L Lopez Ibor
Journal:  Neurosurg Rev       Date:  1986       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.